Clinical Trial Update: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of levofloxacin for treating multidrug-resistant tuberculosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Multidrug-resistant

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Boston University | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24